Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Rheumatology (Oxford, England)|March 12, 2021
COVID-19 vaccination and antirheumatic therapyJack Arnold, Kevin Winthrop, Paul EmeryJournal of Bacteriology|June 29, 2023
Genetic Engineering of Resident Bacteria in the Gut MicrobiomeJack Arnold, Joshua Glazier, Mark MimeeRheumatology (Oxford, England)|February 2, 2026
Interspinous ligamentitis in patients with psoriatic arthritisJack Arnold, Muthusamy Chandramohan, Philip S HelliwellBiotechnology Progress|January 29, 2022
Proceedings from the 3rd International Conference on Microbiome EngineeringSandra McClure, Fatima Enam, Jack Arnold, et al.Radiation Research|October 20, 2010
Effect of low doses of 14 MeV neutrons on polymersAgnès Rivaton, Jack Arnold, Morgane Dos Santos, et al.Schizophrenia Research|July 11, 2017
Sensorimotor gating characteristics of violent men with comorbid psychosis and dissocial personality disorder: Relationship with antisocial traits and psychosocial deprivationOttilie Sedgwick, Susan Young, Ben Greer, et al.The Lancet. Rheumatology|January 30, 2023
Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort studyMd Yuzaiful Md Yusof, Jack Arnold, Benazir Saleem, et al.Frontiers in Immunology|January 31, 2022
A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated VasculitisJack Arnold, Edward M Vital, Shouvik Dass, et al.Radiation Research|October 19, 2002
Simulation of neutron interactions at the single-cell levelJean-Pierre Alard, Véronique Bodez, Andrei Tchirkov, et al.ACR Open Rheumatology|June 6, 2022
Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary Sjögren SyndromeSophanit Pepple, Jack Arnold, Edward M Vital, et al.Pageof 2